Guyer William, Chief Development Officer at Corcept Therapeutics ($CORT), sold common shares on the open market twenty-three times over the last year, totaling $16.2 million. His most recent sale occurred on March 4, 2026. These sales rank 789th among 11,678 individual insiders, surpassing the average sale amount of $8.6 million and average of 6.4 transactions. He made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 20, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 11767 | $36.01 | 2,231.0000 | 119,981,000 | 84.06% | 0.01% |
| March 20, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock Option (right to buy) | 11767 | $0.00 | 210,000.0000 | 119,981,000 | 5.31% | 0.01% |
| March 20, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 11767 | $21.65 | 13,998.0000 | 119,981,000 | 527.43% | 0.01% |
| March 4, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock Option (right to buy) | 8233 | $0.00 | 221,767.0000 | 119,981,000 | 3.58% | 0.01% |
| March 4, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 8233 | $21.65 | 10,464.0000 | 119,981,000 | 369.03% | 0.01% |
| March 4, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 8233 | $35.99 | 2,231.0000 | 119,981,000 | 78.68% | 0.01% |
| March 2, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 498 | $35.97 | 1,733.0000 | 119,981,000 | 40.32% | 0.00% |
| March 2, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 498 | $0.00 | 2,231.0000 | 119,981,000 | 28.74% | 0.00% |
| Feb. 27, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Stock Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 119,981,000 | 9999.99% | 0.12% |
| Feb. 3, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 230,000.0000 | 119,981,000 | 8.00% | 0.02% |
| Feb. 3, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $21.65 | 21,235.0000 | 119,981,000 | 1619.43% | 0.02% |
| Feb. 3, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 20000 | $40.87 | 1,235.0000 | 119,981,000 | 94.18% | 0.02% |
| Jan. 6, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $21.65 | 21,235.0000 | 119,981,000 | 1619.43% | 0.02% |
| Jan. 6, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 250,000.0000 | 119,981,000 | 7.41% | 0.02% |
| Jan. 6, 2026 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 20000 | $35.18 | 1,235.0000 | 119,981,000 | 94.18% | 0.02% |
| Nov. 25, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 4500 | $80.90 | 787.0000 | 119,981,000 | 85.11% | 0.00% |
| Nov. 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | J | Common Stock | 5287 | $0.00 | 5,287.0000 | 119,981,000 | 9999.99% | 0.00% |
| Nov. 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | G | Common Stock | 5287 | $0.00 | 787.0000 | 119,981,000 | 87.04% | 0.00% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 270,000.0000 | 119,981,000 | 6.90% | 0.02% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 640 | $80.88 | 1,235.0000 | 119,981,000 | 34.13% | 0.00% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 19360 | $80.05 | 1,875.0000 | 119,981,000 | 91.17% | 0.02% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $21.65 | 21,235.0000 | 119,981,000 | 1619.43% | 0.02% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | J | Common Stock | 787 | $0.00 | 1,235.0000 | 119,981,000 | 175.67% | 0.00% |
| Dec. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | G | Common Stock | 787 | $0.00 | 1,235.0000 | 119,981,000 | 38.92% | 0.00% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 224 | $0.00 | 448.0000 | 119,981,000 | 100.00% | 0.00% |
| Dec. 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 224 | $79.78 | 224.0000 | 119,981,000 | 9999.99% | 0.00% |
| Nov. 25, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 4500 | $80.90 | 787.0000 | 119,981,000 | 85.11% | 0.00% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 6536 | $74.75 | 18,751.0000 | 119,981,000 | 25.85% | 0.01% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 290,000.0000 | 119,981,000 | 6.45% | 0.02% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 300 | $76.28 | 5,287.0000 | 119,981,000 | 5.37% | 0.00% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 13164 | $75.64 | 5,587.0000 | 119,981,000 | 70.20% | 0.01% |
| Nov. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $21.65 | 25,287.0000 | 119,981,000 | 378.29% | 0.02% |
| Oct. 7, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 20000 | $89.94 | 5,287.0000 | 119,981,000 | 79.09% | 0.02% |
| Oct. 7, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 310,000.0000 | 119,981,000 | 6.06% | 0.02% |
| Oct. 7, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $21.65 | 25,287.0000 | 119,981,000 | 378.29% | 0.02% |
| Sept. 19, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | G | Common Stock | 200 | $0.00 | 5,287.0000 | 113,480,000 | 3.64% | 0.00% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 330,000.0000 | 113,480,000 | 5.71% | 0.02% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $21.65 | 25,487.0000 | 113,480,000 | 364.50% | 0.02% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 15594 | $70.39 | 9,893.0000 | 113,480,000 | 61.18% | 0.01% |
| Sept. 2, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 4406 | $70.85 | 5,487.0000 | 113,480,000 | 44.54% | 0.00% |
| Aug. 8, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 35007 | $71.77 | 5,487.0000 | 113,480,000 | 86.45% | 0.03% |
| Aug. 8, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 35007 | $21.65 | 40,494.0000 | 113,480,000 | 638.00% | 0.03% |
| Aug. 8, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 35007 | $0.00 | 350,000.0000 | 113,480,000 | 9.09% | 0.03% |
| Aug. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 14 | $0.00 | 385,007.0000 | 113,480,000 | 0.00% | 0.00% |
| Aug. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 14 | $71.77 | 5,487.0000 | 113,480,000 | 0.25% | 0.00% |
| Aug. 5, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 14 | $21.65 | 5,501.0000 | 113,480,000 | 0.26% | 0.00% |
| July 18, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 500 | $0.00 | 385,021.0000 | 113,480,000 | 0.13% | 0.00% |
| July 18, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 500 | $73.44 | 5,487.0000 | 113,480,000 | 8.35% | 0.00% |
| July 18, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 500 | $21.65 | 5,987.0000 | 113,480,000 | 9.11% | 0.00% |
| July 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 4379 | $73.48 | 5,487.0000 | 113,480,000 | 44.38% | 0.00% |
| July 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 4379 | $21.65 | 9,866.0000 | 113,480,000 | 79.81% | 0.00% |
| July 17, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 4379 | $0.00 | 385,521.0000 | 113,480,000 | 1.12% | 0.00% |
| July 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 100 | $73.51 | 5,487.0000 | 113,480,000 | 1.79% | 0.00% |
| July 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 100 | $21.65 | 5,587.0000 | 113,480,000 | 1.82% | 0.00% |
| July 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 100 | $0.00 | 389,900.0000 | 113,480,000 | 0.03% | 0.00% |
| June 10, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 3082 | $72.75 | 5,487.0000 | 113,480,000 | 35.97% | 0.00% |
| June 10, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $21.65 | 25,487.0000 | 113,480,000 | 364.50% | 0.02% |
| June 10, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 16918 | $72.36 | 8,569.0000 | 113,480,000 | 66.38% | 0.01% |
| June 10, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 390,000.0000 | 113,480,000 | 4.88% | 0.02% |
| May 16, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 32262 | $74.17 | 5,487.0000 | 113,480,000 | 85.46% | 0.03% |
| May 16, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 32262 | $21.65 | 37,749.0000 | 113,480,000 | 587.97% | 0.03% |
| May 16, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 32262 | $0.00 | 410,000.0000 | 113,480,000 | 7.29% | 0.03% |
| May 6, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 7060 | $74.31 | 5,487.0000 | 113,480,000 | 56.27% | 0.01% |
| May 6, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 7060 | $21.65 | 12,547.0000 | 113,480,000 | 128.67% | 0.01% |
| May 6, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 7060 | $0.00 | 442,262.0000 | 113,480,000 | 1.57% | 0.01% |
| April 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 678 | $114.51 | 5,487.0000 | 113,480,000 | 11.00% | 0.00% |
| April 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 678 | $21.65 | 6,165.0000 | 113,480,000 | 12.36% | 0.00% |
| April 1, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 678 | $0.00 | 449,322.0000 | 113,480,000 | 0.15% | 0.00% |
| March 4, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 20000 | $0.00 | 30,000.0000 | 113,480,000 | 40.00% | 0.02% |
| March 4, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 20000 | $19.26 | 25,487.0000 | 113,480,000 | 364.50% | 0.02% |
| March 4, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 20000 | $59.07 | 5,487.0000 | 113,480,000 | 78.47% | 0.02% |
| Feb. 28, 2025 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Stock option (right to buy) | 140000 | $0.00 | 140,000.0000 | 113,480,000 | 9999.99% | 0.12% |
| Dec. 2, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | F | Common Stock | 309 | $57.68 | 5,487.0000 | 113,723,000 | 5.33% | 0.00% |
| Nov. 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 3394 | $0.00 | 450,000.0000 | 113,723,000 | 0.75% | 0.00% |
| Nov. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 6606 | $0.00 | 453,394.0000 | 113,723,000 | 1.44% | 0.01% |
| Nov. 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 3394 | $48.97 | 5,796.0000 | 113,723,000 | 36.93% | 0.00% |
| Nov. 4, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 3394 | $21.65 | 9,190.0000 | 113,723,000 | 58.56% | 0.00% |
| Nov. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 6606 | $48.97 | 5,796.0000 | 113,723,000 | 53.27% | 0.01% |
| Nov. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 6606 | $21.65 | 12,402.0000 | 113,723,000 | 113.98% | 0.01% |
| Oct. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 10000 | $46.28 | 5,796.0000 | 113,723,000 | 63.31% | 0.01% |
| Oct. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 10000 | $21.65 | 15,796.0000 | 113,723,000 | 172.53% | 0.01% |
| Oct. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 10000 | $0.00 | 460,000.0000 | 113,723,000 | 2.13% | 0.01% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 10000 | $35.30 | 6,039.0000 | 111,742,000 | 62.35% | 0.01% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 10000 | $21.65 | 16,039.0000 | 111,742,000 | 165.59% | 0.01% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 10000 | $0.00 | 470,000.0000 | 111,742,000 | 2.08% | 0.01% |
| Sept. 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | F | Common Stock | 243 | $35.30 | 5,796.0000 | 111,742,000 | 4.02% | 0.00% |
| Aug. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 10000 | $38.67 | 6,039.0000 | 111,742,000 | 62.35% | 0.01% |
| Aug. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 10000 | $21.65 | 16,039.0000 | 111,742,000 | 165.59% | 0.01% |
| Aug. 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 10000 | $0.00 | 480,000.0000 | 111,742,000 | 2.04% | 0.01% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 10000 | $21.65 | 16,039.0000 | 111,742,000 | 165.59% | 0.01% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 10000 | $0.00 | 490,000.0000 | 111,742,000 | 2.00% | 0.01% |
| July 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 10000 | $32.49 | 6,039.0000 | 111,742,000 | 62.35% | 0.01% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 10000 | $19.26 | 16,039.0000 | 111,742,000 | 165.59% | 0.01% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 10000 | $0.00 | 50,000.0000 | 111,742,000 | 16.67% | 0.01% |
| June 3, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 10000 | $32.00 | 6,039.0000 | 111,742,000 | 62.35% | 0.01% |
| May 28, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 30000 | $19.26 | 36,039.0000 | 111,742,000 | 496.77% | 0.03% |
| May 28, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock option (right to buy) | 30000 | $0.00 | 60,000.0000 | 111,742,000 | 33.33% | 0.03% |
| May 28, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 30000 | $32.00 | 6,039.0000 | 111,742,000 | 83.24% | 0.03% |
| March 1, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | F | Common Stock | 604 | $24.06 | 6,039.0000 | 111,742,000 | 9.09% | 0.00% |
| Feb. 9, 2024 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 111,742,000 | 9999.99% | 0.18% |
| Dec. 22, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | S | Common Stock | 10000 | $32.00 | 6,643.0000 | 115,966,000 | 60.09% | 0.01% |
| Dec. 22, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Common Stock | 10000 | $19.26 | 16,643.0000 | 115,966,000 | 150.53% | 0.01% |
| Dec. 22, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | M | Stock Option (right to buy) | 10000 | $0.00 | 90,000.0000 | 115,966,000 | 10.00% | 0.01% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 609 | $0.00 | 6,643.0000 | 115,966,000 | 10.09% | 0.00% |
| Dec. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 609 | $25.97 | 6,034.0000 | 115,966,000 | 11.23% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 478 | $33.10 | 5,266.0000 | 115,966,000 | 9.98% | 0.00% |
| Sept. 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 478 | $0.00 | 5,744.0000 | 115,966,000 | 9.08% | 0.00% |
| March 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 1472 | $19.86 | 3,316.0000 | 115,966,000 | 79.83% | 0.00% |
| March 1, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Common Stock | 1472 | $0.00 | 4,788.0000 | 115,966,000 | 44.39% | 0.00% |
| Feb. 13, 2023 | CORCEPT THERAPEUTICS INC | $CORT | Guyer William | Chief Development Officer | A | Stock option (right to buy) | 200000 | $0.00 | 200,000.0000 | 115,966,000 | 9999.99% | 0.17% |